BlueLinx price target lowered to $83 from $110 at Benchmark

Benchmark analyst Reuben Garner lowered the firm’s price target on BlueLinx (BXC) to $83 from $110 and keeps a Buy rating on the shares. BlueLinx reported “solid” Q2 results, but the firm’s EPS estimates for FY25 and FY26 come down “meaningfully” to $1.75 and $3.00, respectfully, given macro expectations for the second half of the year and the company’s investment pace, the analyst tells investors.